Safely ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy

Archives of Disease in Childhood

Volumn 97, Issue 12, 2012, Pages 1014-1018

  Van Vijver, Els De ^a   Schreuder, Andrea Bertilde ^b   Cnossen, Wybrich Riemke ^c   Kobold, Anna Caecilia Muller ^b   Van Rheenen, Patrick Ferry ^b   Gonera de Jong, Gieneke ^d   Uitentuis, Jan ^e   Norbruis, Obbe F ^f   Van Overbeek, Lidy A T ^g   Van Dorth, Stefan ^h   Waalkens, Herman J ⁱ  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Wilhelmina Ziekenhuis   (Netherlands)

^e MEDICAL CENTER LEEUWARDEN   (Netherlands)

^f ISALA HOSPITAL   (Netherlands)

^g Scheper Ziekenhuis   (Netherlands)

^h De Tjongerschans Hospital   (Netherlands)

ⁱ MARTINI HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOSCOPY; ENTERITIS; FECES ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; ULCERATIVE COLITIS;

ADOLESCENT; CHILD; ENDOSCOPY, GASTROINTESTINAL; FECES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; SENSITIVITY AND SPECIFICITY;

EID: 84869890246     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2011-301206     Document Type: Article

References (15)

1. van Rheenen PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 2010;341:c3369.
2. Fagerberg UL, Loof L, Merzoug RD, et al. Fecal calprotectin levels in healthy children studied with an improved assay. J Pediatr Gastroenterol Nutr 2003;37:468-72.
3. Rugtveit J, Fagerhol MK. Age-dependent variations in fecal calprotectin concentrations in children. J Pediatr Gastroenterol Nutr 2002;34:323-4.
4. World Health Organization. Iron Deficiency Anaemia: Assessment, Prevention, and Control. A Guide for Programme Managers. Geneva: World Health Organization, 2001.
5. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis - the Porto criteria. J Pediatr Gastroenterol Nutr 2005;41:1-7.
6. Diamanti A, Panetta F, Basso MS, et al. Diagnostic work-up of inflammatory bowel disease in children: the role of calprotectin assay. Inflamm Bowel Dis 2010;16:1926-30.
7. Henderson P, Casey A, Lawrence SJ, et al. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease. Am J Gastroenterol 2012 ;107:941-9.
8. Knottnerus JA, Dinant GJ. Medicine based evidence, a prerequisite for evidence based medicine. BMJ 1997;315:1109-10.
9. Bremner A, Roked S, Robinson R, et al. Faecal calprotectin in children with chronic gastrointestinal symptoms. Acta Paediatr 2005;94:1855-8.
10. Dolwani S, Metzner M, Wassell JJ, et al. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology. Aliment Pharmacol Ther 2004;20:615-21.
11. Tibble JA, Sigthorsson G, Foster R, et al. High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 1999;45:362-6.
12. Poullis A, Foster R, Mendall MA, et al. Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity. Eur J Gastroenterol Hepatol 2003;15:573-4.
13. Shulman RJ, Eakin MN, Czyzewski DI, et al. Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome. J Pediatr 2008;153:646-50.
14. Pewsner D, Battaglia M, Minder C, et al. Ruling a diagnosis in or out with 'SpPIn' and 'SnNOut': a note of caution. BMJ 2004;329:209-13.
15. Tsampalieros A, Griffiths AM, Barrowman N, et al. Use of C-reactive protein in children with newly diagnosed inflammatory bowel disease. J Pediatr 2011;159:340-2.